2023 - Research.com Biology and Biochemistry in Spain Leader Award
Carmelo Bernabeu spends much of his time researching Endoglin, Cell biology, Molecular biology, Transforming growth factor and Transforming growth factor beta. The study incorporates disciplines such as Cancer research, Angiogenesis, Receptor, Receptor complex and Signal transduction in addition to Endoglin. His work is dedicated to discovering how Angiogenesis, Endocrinology are connected with Macrophage polarization and Granulocyte macrophage colony-stimulating factor and other disciplines.
His work in the fields of SMAD, Focal adhesion, Zyxin and Kinase overlaps with other areas such as LIM domain. His work carried out in the field of Molecular biology brings together such families of science as Cell culture, Transfection, Antigen, Molecular cloning and Monoclonal antibody. He has included themes like Endothelial stem cell, Downregulation and upregulation, Sp1 transcription factor and COS cells in his Transforming growth factor beta study.
Carmelo Bernabeu spends much of his time researching Endoglin, Molecular biology, Cell biology, Cancer research and Internal medicine. His Endoglin research includes themes of Receptor, Receptor complex, Transforming growth factor and Angiogenesis. The concepts of his Molecular biology study are interwoven with issues in Cell culture, Biochemistry, Antigen and Antibody, Monoclonal antibody.
In his research on the topic of Cell biology, Cell adhesion is strongly related with Integrin. The various areas that Carmelo Bernabeu examines in his Cancer research study include Carcinogenesis, Cancer, Cell growth, Pathology and Signal transduction. Carmelo Bernabeu usually deals with Internal medicine and limits it to topics linked to Endocrinology and Soluble endoglin, Inflammation and Downregulation and upregulation.
His primary areas of study are Endoglin, Telangiectases, Cell biology, Internal medicine and ACVRL1. His Endoglin research incorporates themes from Cancer research, Angiogenesis, Inflammation, Downregulation and upregulation and Mesenchymal stem cell. Carmelo Bernabeu combines subjects such as Receptor, Chinese hamster ovary cell, Receptor complex, Galectin-3 and Glycoprotein with his study of Cancer research.
His studies deal with areas such as Integrin and Co-receptor as well as Cell biology. Carmelo Bernabeu works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Soluble endoglin and Function, as a part of the same area of interest. His ACVRL1 research is multidisciplinary, relying on both Mutation, Transfection, Expression vector, Molecular biology and Exon.
Carmelo Bernabeu focuses on Endoglin, Angiogenesis, Cell biology, Inflammation and Internal medicine. His study in Endoglin is interdisciplinary in nature, drawing from both Cancer research, Progenitor cell, Perfusion, TGF beta signaling pathway and Integrin. His Angiogenesis research is multidisciplinary, incorporating perspectives in Haploinsufficiency and ACVRL1.
His Cell biology study frequently draws connections between related disciplines such as Cell type. His Inflammation research is multidisciplinary, incorporating elements of Cell, Cell surface receptor, Downregulation and upregulation, Macrophage polarization and Endothelium. In Internal medicine, Carmelo Bernabeu works on issues like Endocrinology, which are connected to Aorta.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.
S Cheifetz;T Bellón;C Calés;S Vera.
Journal of Biological Chemistry (1992)
Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.
Tilman Sánchez-Elsner;Luisa María Botella;Beatriz Velasco;Angel L. Corbí.
Journal of Biological Chemistry (2001)
TGF-β/TGF-β receptor system and its role in physiological and pathological conditions
Juan F. Santibañez;Miguel Quintanilla;Carmelo Bernabeu.
Clinical Science (2011)
Endoglin modulates cellular responses to TGF-beta 1.
P Lastres;A Letamendía;H Zhang;C Rius.
Journal of Cell Biology (1996)
Endoglin Expression Is Regulated by Transcriptional Cooperation between the Hypoxia and Transforming Growth Factor-β Pathways
Tilman Sánchez-Elsner;Luisa María Botella;Beatriz Velasco;Carmen Langa.
Journal of Biological Chemistry (2002)
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells.
Chenggang Li;Ian N Hampson;Lynne Hampson;Patricia Kumar.
The FASEB Journal (2000)
The emerging role of TGF-β superfamily coreceptors in cancer
Carmelo Bernabeu;Jose M. Lopez-Novoa;Miguel Quintanilla.
Biochimica et Biophysica Acta (2009)
Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan
Ainhoa Letamendía;Pedro Lastres;Luisa María Botella;Ulla Raab.
Journal of Biological Chemistry (1998)
Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions
Teresa Bellón;Angel Corbi;Pedro Lastres;Carmela Calés.
European Journal of Immunology (1993)
Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen.
Pedro Lastres;Teresa Bellon;Carlos Cabañas;Francisco Sanchez-Madrid.
European Journal of Immunology (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: